1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Clesrovimab: new trials by email Literature Review of Clesrovimab trials Research Report on Clesrovimab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability, and Pharmacokinetics of Clesrovimab (MK-1654) in Infants (MK-1654-002) Clesrovimab, Placebo - Respiratory Tract Infection, Respiratory Syncytial Virus | Phase 1 / Phase 2 | Completed | Merck Sharp & Dohme LLC | 183 | 2018-09-20 | 2025-01-14 |
Respiratory Tract Infections (1)
Chile (1) · Colombia (1) · South Africa (1) · South Korea (1) · Spain (1) · United States (1)
2017 (1)